Clinical Trial Update: CHiR Therapy for Elderly DLBCL Intolerant to Chemo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CHiR Therapy for elderly patients with diffuse large B-cell lymphoma intolerant to chemotherapy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CHiR Therapy

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING